News & Updates

Sibylla’s PPI-FIT technology joins with MD Anderson’s drug development resources and expertise to create protein...

Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System...

Sibylla Biotech Appoints Dominique Bridon as Executive Chairman of the Board Milan, Italy, September 28, 2023 –...

Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand...

Giovanni Spagnolli appointed as CTO of Sibylla Biotech

Sibylla Biotech selected by Nature among the eight best start-ups in the world in the life-science sector Sibylla...

Sibylla Biotech will use its Drug Discovery platform to modulate the activity of targets supplied by Takeda. The...

The scientific paper about PPI-FIT technology and its first validation is now published on Nature Communications...

New structural target against COVID-19 A new structural target for drug development against COVID-19 has been unveiled...

A documentary on Sibylla Biotech broadcasted on TV 4.0 La fabbrica del futuro

Interview with one of the inventor of the PPI-FIT technology and co-founder of Sibylla Biotech 

Watch the interview in italian

Watch the press release in italian Interview link

Lidia Pieri appointed as CEO of Sibylla Biotech